Objectives/Hypothesis: To develop a vocal fold scarring model using an ablative laser in the rabbit as a platform for testing bioengineered therapies for missing or damaged lamina propria.
INTRODUCTION
Vocal fold scarring is a significant cause of poor voice quality following vocal fold injury. 1 The development of novel therapies for the prevention and treatment of vocal fold scarring has been the focus of intense investigation for well over a decade. Current tissueengineering approaches encompass cell-based therapy, growth factor modulation, and the development of extracellular matrix (ECM) scaffolds. 2, 3 Animal models have been critical to the process of evaluating the functional performance of these therapies in vivo. 4 The rabbit has been heavily utilized because of the similarities of its vocal fold microstructure to that of human vocal folds, the relative accessibility of its vocal folds to surgical manipulation, its inherent nonvocal nature, and its lower cost compared to larger species. 5 Previously reported methods to create vocal fold injury in the rabbit include Cup-forceps biopsies, 6, 7 vocal fold stripping, 8 laser ablation, 9 and microflap incision. 10 In some cases, the injury extended to the cartilaginous glottis or deep into muscle. 9, 11 As most current research in vocal fold tissueengineering focuses on the regeneration of the lamina propria, it would be advantageous to have an injury model for which the injury depth is largely confined to the lamina propria, does not involve total loss of the lamina propria, simulates vocal fold injuries in humans, and can be created with precision in a graded manner.
We present a pilot study to establish the feasibility of a vocal fold injury model in the rabbit using a holmium:YAG (Ho:YAG) laser. The Ho:YAG laser operates at a characteristic wavelength of 2,100 nm with water as the target chromophore. It has been used in a variety of otolaryngologic procedures, including airway surgery. 12, 13 We sought to take advantage of its ability to deliver quantized energy through a submillimeter-diameter fiber to create defined ablative wounds. The objectives of this study were: 1) to demonstrate the feasibility of creating controlled vocal fold injury using the Ho:YAG laser in a rabbit model, and 2) to characterize the lamina propria deficit created in this model. We hypothesized that the laser injury would result in a lamina propria deficit without gross damage to the underlying muscle.
The overall goal is to establish a vocal fold scarring model as a platform for testing novel bioengineered lamina propria regenerative therapeutics.
MATERIALS AND METHODS

Determination of Optimal Laser Energy Level
A preliminary study was carried out to determine the optimal laser energy level using intact cadaveric larynges from three rabbits sacrificed for unrelated experiments. The larynges were harvested immediately postmortem, and the laser treatment performed shortly after. The Ho:YAG laser (Lumenis VersaPulse PowerSuite, Santa Clara, CA; 2.1 lm) at 600 mJ/pulse was delivered via a 365-micron fiber. Laser treatment was performed in contact mode, that is, the fiber tip just touching the vocal fold surface but not pressing into the mucosa. One vocal fold in each larynx was treated, whereas the other vocal fold served as the control. The experimental vocal fold was treated at three locations along the membranous vocal fold: one spot just anterior to the vocal process, one spot at the mid-membranous vocal fold, and one spot just short of the anterior commissure. These three spots were approximately equidistant. In the first larynx, one pulse was applied at each spot (0.6 J). In the second larynx, three pulses were applied at each spot (1.8 J). In the third larynx, five pulses were applied at each spot (3.0 J). The larynges were then fixed in formalin for histologic processing.
Animals and Surgical Procedure
The experimental protocol was approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center, in accordance with the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals, the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23, revised 1985), and the Animal Welfare Act (7 U.S.C. et seq.). Eight New Zealand white rabbits weighing 2.8 to 3.4 kg underwent direct laryngoscopy, during which laser injury was created on one vocal fold (detailed below), with the other vocal fold serving as control. General anesthesia was induced with intramuscular administration of ketamine (35 mg/kg) and xylazine (3 mg/kg). Buprenorphine (0.02 mg/kg) was administered after induction and prior to laryngoscopy. Heart rate, temperature, respiratory rate, and oxygen saturation level were monitored. Suspension laryngoscopy was performed with a no. 1 Miller blade. Vocal fold intervention was performed under visual guidance using a 2.7-mm, 30-degree Hopkins telescope (Karl Storz, Tuttlingen, Germany). Four percent lidocaine was dripped onto the arytenoids prior to laser application. The Ho:YAG laser at 600 mJ/pulse was delivered via a 365-micron fiber. Laser treatment was performed in contact mode. The laser fiber was threaded through a 20G spinal needle and directed to the membranous vocal fold (Fig. 1) . For each animal, one vocal fold was treated, whereas the other vocal fold served as uninjured control. The experimental vocal fold was treated at three spots along the membranous vocal fold: one spot just anterior to the vocal process, one spot at the mid-membranous vocal fold, and one spot just short of the anterior commissure (Fig. 1 ). These three spots were approximately equidistant. At each spot, three pulses were delivered-for 1.8 J per spot or for 5.4 J per vocal fold. The animal was then recovered.
Excised Larynx Phonation, High-Speed Imaging, and Videokymography
Four weeks after laser injury, the animals were sacrificed and their larynges harvested. Four of the eight larynges were subjected to excised larynx phonation, which was induced as previously described.
14 Subglottal airflow was slowly increased until audible phonation occurred. As soon as phonation began, high-speed imaging data were acquired at 6,000 frames per second using a Phantom V311 high-speed camera (Vision Research, Wayne, NJ) and Nikkon micro lens (Nikkon, Melville, NY) mounted over the larynx. The videos were inspected to identify the earliest segment of stable vibratory behavior following phonation onset. Videokymographic images were generated by custom software from a transverse line taken from the high-speed images at the location of the greatest amplitude during vocal fold vibration, which is typically at the mid-membranous vocal fold. The videokymographic images were then manually analyzed using ImageJ (NIH, Bethesda, MD) to measure the amplitude of vibration, defined as the difference between the vocal fold edge position at the maximum opening and closing phases of vibration.
Histology and Immunohistochemistry
The larynges were fixed in 10% formalin, decalcified in 0.35 M ethylenediaminetetraacetic acid, then embedded in paraffin for sectioning. Successive 5.0-mm thick coronal sections of the laryngeal specimens were prepared. Hematoxylin and eosin (H&E) staining was performed using standard methods. Immunohistochemical (IHC) stainings for collagen type I, collagen type III, elastin, and hyaluronic acid (HA) were carried out, as previously described. 15, 16 For collagen type I, collagen type III, and elastin, sections were first incubated in Proteinase K (Sigma, St. Louis, MO) epitope retrieval buffer for 15 minutes at 37 o C and then incubated in Pierce Peroxidase Suppressor solution (Thermo Fisher Scientific, Rockford, IL), followed by 5% bovine serum albumin (BSA) (Sigma, St. Louis, MO) blocking buffer with serial washings in between each step. Biotinylated anti-collagen type I antibody (Millipore, Billerica, MA), anti-collagen type III antibody (MP Biomedicals, Santa Ana, CA), anti-elastin antibody (Millipore, Billerica, MA), and biotinylated hyaluronic acid binding protein (Calbiochem, San Diego, CA) were applied overnight at 4 C or for 4 hours at 37 C. After unbound primary antibodies were washed off, sections were incubated with horseradish peroxidase-conjugated streptavidin (for collagen type I and HA; Thermo Fisher Scientific, Rockford, IL) or anti-mouse IgG-peroxidase secondary antibody (for collagen type III and elastin; Sigma, St. Louis, MO) at room temperature for 1 to 1.5 hours. The sections were then incubated with Pierce metal-enhanced diaminobenzidine peroxidase substrate solution (Thermo Fisher Scientific, Rockford, IL) for 2 minutes. Epiglottic tissue served as positive controls. Laryngeal sections with the primary antibody replaced by BSA were used as negative controls.
Quantitative Histological Analysis
Histological and IHC images were captured with a Leica DM200 microscope (Bannockburn, IL) and a MicroFire microscope CCD digital camera (Optronics, Goleta, CA). The relative densities of collagen type I, collagen type III, elastin, and HA were estimated from their staining intensities and relative areas, as previously described in detail 15, 16 and briefly summarized here. Color images were first converted to 8-bit grayscale images in Photoshop (Adobe, San Jose, CA). For each grayscale image, visual comparisons were made with its corresponding H&E stained image in order to select lower-level and upperthreshold values so that pixels representing areas of the molecule of interest can be clearly visualized with minimal background. Pixels with intensities bracketed by the thresholds were deemed representative of the molecule of interest. The relative density of the molecule of interest was then calculated as the fraction of the positively stained area to the total area of the vocal fold lamina propria using Image J.
Statistical Analysis
Paired Student's t tests were applied to vibrational amplitudes from high-speed imaging and the relative densities on histology and IHC staining with alpha 5 0.05.
RESULTS
Laser Injury
An intraoperative photograph is shown in Figure 1 . Figure 2 shows the extent of injury created by the Ho:YAG laser at various energy levels in fresh cadaveric rabbit larynges. At 0.6 J, only the epithelium and part of the lamina propria were disrupted ( Fig. 2A) . At 1.8 J, the ablation extends through the lamina propria to the superficial part of the muscle (Fig. 2B) . At 3.0 J, a large muscle deficit was produced (Fig. 2C) . Based on these results, 1.8 J was chosen for the survival experiments. Figure 3 shows representative coronal sections of the larynx harvested 4 weeks after laser treatment. Collagen type I, localized to the deeper aspect of the lamina propria in the normal vocal fold (Fig. 3B, right) , is present through the entire thickness of the lamina propria in the scarred vocal fold (Fig. 3B, left) . There is no appreciable difference in the morphological distribution of collagen type III and elastin between the normal and scarred vocal folds (Fig. 3C, D) . HA, which can be seen as a continuous band in the lamina propria extending from the supraglottis to the subglottis in the normal vocal fold (Fig. 3E,F, right) , is noticeably deficient at the location of the laser injury in the scarred vocal fold (Fig.  3E,F, left) .
Histology and IHC Staining
The relative densities of select ECM constituents in IHC staining are plotted in Figure 4 . Collagen type I was present at higher levels in the scarred vocal folds (P 5 0.003). Collagen type III density was similar between normal and scarred vocal folds. Elastin was higher in scarred vocal folds (P 5 0.022), whereas HA was lower in the scarred vocal folds (P 5 0.030).
High-Speed Imaging and Videokymography
A representative videokymograph from excised larynx phonation is shown in Figure 5 . The scarred vocal folds vibrated with a mean amplitude of 0.18 mm (SD 5 0.02 mm), whereas the control vocal folds vibrated with a mean amplitude of 0.31 mm (SD 5 0.10 mm). This difference was statistically significant (P 5 0.036; n 5 4).
DISCUSSION
Small animal models such as the rabbit or rat 17 have been indispensible in the development of novel tissue-engineering therapies for damaged or missing vocal fold lamina propria. A well-established experimental paradigm consists of the intentional creation of a vocal fold wound preceded or followed by the therapeutic intervention. However, the much smaller size of the animal larynx often precludes the degree of precision that is possible in human vocal fold surgeries. Although vocal fold microflap elevation has been demonstrated in the rabbit, 10 it is not meant as a way to create scar, and vibratory function returns to normal within a week. 18 Cup forceps biopsy, which is a well-accepted vocal fold injury method in animal models, in theory could limit the size of the mucosal defect to the size of the cup. In our experience, the mucosal defect tends to be larger than the cup size, because the rabbit vocal fold mucosa is highly elastic, and the defect is created by a ripping rather than cutting action. Even a relatively small cup size, for example, 1 mm, is far greater than the thickness of the lamina propria (e.g., Fig. 2 ). These vocal fold injury methods in small animal models may produce an exaggerated wound healing response relative to lamina propria scarring in humans, a concern that has been raised before. 19, 20 The present work is an attempt to establish a vocal fold scarring model for which the extent of injury can be controlled with some precision. The intent is to generate a response that primarily reflects injury to the lamina propria rather than injury to the muscle underneath.
We chose to examine the histologic and vibratory responses at 4 weeks postinjury in this pilot study for several reasons. Gene expression levels of inflammatory cytokines have been shown to return to baseline by 21 days following cup forceps biopsy of rabbit vocal folds. 21 Similarly, histological features of rat vocal folds recovered to normal at 1 month following pulsed dye laser irradiation. 22 By 4 weeks, the inflammatory and proliferative phases of wound healing are complete and the wound should be in the remodeling phase, which is considered to start by week 3.
23 Therefore, our findings at 4 weeks after injury should reflect scarring and not the reparative process that would have restored normal tissue architecture within the first 2 to 4 weeks.
Collagen type I is sparse in normal vocal folds and is upregulated in response to injury. Its level peaks at day 5 following vocal fold injury in a rat model and declines after 8 weeks-but remains elevated above uninjured controls through 12 weeks. 24, 25 Chronic vocal fold scar is characterized by the excessive deposition of disorganized collagen type I. 23, 25 Collagen type III is abundant throughout the normal human vocal fold lamina propria 26 but more concentrated in the deep layer. 27 It tends to be more highly concentrated in dynamic regions of elastic tissues and is considered to play a role in maintaining the structure of the ECM. 27 In a rat model, it was shown to be upregulated in response to injury, with its level remaining elevated throughout 12 weeks postinjury and presumably throughout the remodeling phase of wound healing. 25 In our current model of vocal fold scarring from laser injury, collagen type I was clearly increased (Fig. 3B) , whereas collagen type III was not significantly different from control. Our collagen type III data do not necessarily conflict with the previously reported findings in the rat model; the authors also noted that "the scores of type III (collagen) in scarred vocal folds showed neither a statistical difference from controls nor a difference among study groups (from 2-12 weeks)." 25 Elastin, which is present in high concentrations in the intermediate layer of the normal human vocal fold lamina propria and is central to the viscoelasticity of the vocal fold, is known to be fragmented and disorganized in scarred lamina propria. 23, 28 Our results showed elastin to be increased in the scarred vocal fold, consistent with other reports. 29 HA is a major component of the vocal fold lamina propria ECM and plays a key role in determining the biomechanical properties of the vocal fold cover. 30 It is also considered to play an important role in early-stage wound healing by acting as a matrix to support and guide fibroblast migration and by minimizing the acute inflammatory response that leads to scar formation. 19 Because of the importance of HA, research efforts have focused on the development of HA-based bioengineered therapeutics to minimize vocal fold scarring and to restore normal lamina propria function. 20, 31 In animal models of acute vocal fold injury, HA levels have been shown to be decreased compared to normal between days 1 to 15 after injury, except for a transient increase at day 5 to a level comparable to preinjury. 19, 24 By 2 months after injury, HA remains reduced 25 or recovers to normal levels. 5, 23, 28 In the current vocal fold scarring model, HA remains decreased at 4 weeks postinjury, which is consistent with the prior reports. Because this model provides a baseline of decreased HA, it appears suitable for the testing of bioengineered therapeutics aimed to increase HA content in injured vocal folds.
One benefit of using an ablative laser to create vocal fold injury in an animal model is that it may mimic vocal fold scarring in humans caused by certain vocal fold surgeries that employ a laser. Laser surgery has had a long history in the treatment of benign and malignant vocal fold lesions. In particular, transoral laser microsurgery (TLM) using the CO 2 laser has gained wide acceptance as a minimally invasive surgical modality for the treatment of laryngeal cancers. 32 Whereas heat transfer to normal tissue abutting a tumor is in theory minimized by using a pulsed laser, some degree of thermal damage along the laser incision is inevitably present and likely contributes to scarring. 33 Therefore, vocal fold scarring following TLM may be better mimicked using an ablative laser injury model. The Ho:YAG laser and CO 2 laser share water as the chromophore, and the healing response to tissue injury induced by both lasers has indeed been shown to be comparable in canine vocal folds. 34 In contrast, the pulsed potassium titanyl phosphate (KTP) laser, another commonly used laser in vocal fold surgery, is utilized for its theoretical angioselective rather than its ablative properties, and it induces tissue changes that fully return to normal by 4 weeks in a rat model. 35 The rabbit vocal fold scarring model in the current study is not intended to replicate the effect of the pulsed KTP laser.
There are several limitations to this work. It does not specifically address whether tissue injury caused by cold instruments differs from injury induced by laser. It has not been demonstrated that this model produces scarring resembling that caused by laser injury in human vocal folds. However, our intent was not to develop a model to specifically study thermal injury. The current work is a pilot study to demonstrate the feasibility of an alternative vocal fold scarring model. Larger-scale studies using this model to test lamina propria tissue engineered therapies are underway in our laboratory.
CONCLUSION
We demonstrate the feasibility of using the Ho:YAG laser to create a vocal fold injury model in the rabbit. An optimal laser energy level was identified to induce lamina propria scarring without extensive muscle deficit. The injured vocal fold showed a histologic profile of ECM constituents that is generally consistent with vocal fold scarring in earlier models. This model may serve as an alternative for studying the effects of novel bioengineered therapies for vocal fold scarring.
